The results showed that ARNTL2 expression levels were closely associated with TNM stage, lymph node metastasis, tumor size, and vascular invasion (Fig. 1e and Table 1). This evidence concerns the gene BMAL2 and metastatic malignant neoplasm in the lymph nodes.